To Prescribe or Not to Prescribe? Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path

Rachel P. Winograd, Bridget Coffey, Candice Woolfolk, Claire A. Wood, Vinith Ilavarasan, David Liss, Subodh Jain, Erin Stringfellow

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

This study aimed to identify the strongest barriers and motivators associated with each step toward buprenorphine prescribing (1. obtaining a waiver, 2. beginning to prescribe, and 3. prescribing to more people) among a sample of Missouri-based medical professionals (N = 130). Item weights (number of endorsements times mean rank of the item’s importance) were calculated based on their responses. Across groups, lack of access to psychosocial support services, need for higher levels of care, and clinical complexity were strong barriers. Among non-prescribers (n = 57, 46.3%), administrative burden, potential of becoming an addiction clinic, and concern about misuse and diversion were most heavily weighted. Among prescribers (n = 66, 53.7%), patients’ inability to afford medications was a barrier across phases. Prominent motivators among all groups were the effectiveness of buprenorphine, improvement in other health outcomes, and a personal interest in treating addiction. Only prescribers reported the presence of institutional support and mentors as significant motivators.

Original languageEnglish
Pages (from-to)165-180
Number of pages16
JournalJournal of Behavioral Health Services and Research
Volume50
Issue number2
DOIs
StatePublished - Apr 2023

Keywords

  • Barriers
  • Buprenorphine
  • Motivators
  • Opioid use disorder
  • Treatment
  • Waiver

Fingerprint

Dive into the research topics of 'To Prescribe or Not to Prescribe? Barriers and Motivators for Progressing Along Each Stage of the Buprenorphine Training and Prescribing Path'. Together they form a unique fingerprint.

Cite this